TMRW Life Sciences, the creator of the only FDA-cleared automated specimen management and storage platform for frozen human sperm, eggs, and embryos, has successfully closed a $28+ million Series D equity financing round. This funding aims to meet the increasing demand from fertility clinics for safe and more accurate cryostorage solutions. The financing round was led by 5AM Ventures, with participation from…
![](https://femtechinsider.com/wp-content/uploads/2022/11/TMRW_Life_Sciences_CryoRobot_Select.jpeg)